Table 2.
Strategy | Proposed purpose | Directions |
---|---|---|
Dose modifications (delays and reductions) | To limit the corneal exposure of belamaf, as the corneal surface regenerates and repairs itself11 | • The eye care professional will determine the highest grade/severity of the corneal event per KVA scale (Table 1), clearly communicate this to the hematologist/oncologist, and continue to monitor these events22,23. The hematologist/oncologist will delay and/or reduce belamaf dose based on the KVA scale guidelines for the most severe eye examination finding |
Regular use of preservative-free lubricant eye drops | To lubricate the cornea and relieve discomfort of subjective dry eye symptoms29; may decrease risk of corneal symptoms23 | • Advise patients to use preservative-free lubricant eye drops at least 4 times a day in both eyes, starting with the first infusion and continuing until end of treatment22,23 |
Avoiding use of contact lenses unless clinically warranted. An eye care professional may direct the patient to use bandage contact lenses | Contact lenses may irritate the cornea30. Bandage contact lenses help protect and aide in repair of the corneal epithelium27 |
• Begin at the first infusion and continue throughout treatment22,23 • Relevant to both eyes |
Belamaf belantamab mafodotin, KVA keratopathy and visual acuity.